BIOMAT Database Logo BIOMAT Database Logo

Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells. 1987

A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
Institut National de la Santé et de la Recherche Médicale U131, Clamart, France.

A high m.w. B cell growth factor (50,000 BCGF) prepared from lectin-activated human peripheral blood lymphocyte culture supernatants acts only on B cells preactivated by a first signal. This first signal can be delivered in vitro (with anti-mu antibody (Ab)) or in vivo. Upon costimulation with anti-mu Ab the 50,000 BCGF induces an early and transient proliferative response, whereas the response to interleukin 2 (IL-2) develops more progressively. To determine the respective targets of the 50,000 BCGF and of IL-2, B cells were activated with anti-mu Ab and separated according to the expression of the IL-2 receptor (cluster designation (CD)25 antigen). CD25+ B cells do not respond to the 50,000 BCGF and do not acquire this responsiveness after an additional culture with IL-2. CD25- B cells respond to the 50,000 BCGF and not to IL-2. However, when CD25- B cells are cultured for 3 days with the 50,000 BCGF they become responsive to IL-2. These results demonstrate a pathway of B cell activation based on the ordered and sequential action of anti-mu Ab, the 50,000 BCGF, and IL-2.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
Human interleukin 7 is a B cell growth factor for activated B cells.
March 1991, European journal of immunology,
A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
December 1985, European journal of immunology,
A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
Interleukin 2 and low molecular weight B cell growth factor are T cell-replacing factors for different subpopulations of human B cells.
October 1988, European journal of immunology,
A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells.
November 1985, Cellular immunology,
A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
Differential effects of interleukin 2 vs B cell growth factor on human B cells.
January 1988, Journal of immunology (Baltimore, Md. : 1950),
A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
Identification of a receptor for high molecular weight human B cell growth factor.
August 1988, Journal of immunology (Baltimore, Md. : 1950),
A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
Identification of a cDNA for a human high molecular-weight B-cell growth factor.
July 1996, Proceedings of the National Academy of Sciences of the United States of America,
A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
Identification of a cDNA for a human high-molecular-weight B-cell growth factor.
July 1993, Proceedings of the National Academy of Sciences of the United States of America,
A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
September 1987, Journal of immunology (Baltimore, Md. : 1950),
A Vazquez, and M T Auffredou, and J P Gerard, and J F Delfraissy, and P Galanaud
Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
November 1989, The Journal of clinical investigation,
Copied contents to your clipboard!